Opsin-binding ligands, compositions and methods of use
AssigneeBikam Pharmaceuticals, Inc.
InventorsDavid S. Garvey, Gregory J. Larosa, Jeremy R. Greenwood, Leah L. Frye, Tan Quach, Jamie B. Cote, Judd Berman
Life of this patent
Estimating the term…
Loading patent…
AssigneeBikam Pharmaceuticals, Inc.
InventorsDavid S. Garvey, Gregory J. Larosa, Jeremy R. Greenwood, Leah L. Frye, Tan Quach, Jamie B. Cote, Judd Berman
Estimating the term…
Compounds are disclosed that are useful for treating ophthalmic conditions caused by or related to production of toxic visual cycle products that accumulate in the eye, such as dry adult macular degeneration, as well as conditions caused by or related to the misfolding of mutant opsin proteins and/or the mis-localization of opsin proteins. Compositions of these compounds alone or in combination with other therapeutic agents are also described, along with therapeutic methods of using such compounds and/or compositions. Methods of synthesizing such agents are also disclosed.
A compound of Formula I,
-4. (canceled)
-49. (canceled)
A method of treating or preventing an ophthalmic condition in a subject at risk thereof, comprising administering to the subject an effective amount of a compound of Formula I
-80. (canceled)
A method of treating or preventing an ophthalmic condition in a subject at risk thereof, comprising administering to the subject an effective amount of a compound of selected from the group consisting of:
Dependencies are inferred from the claim text.